Voloridge Investment Management 13F: New $170M Stake in DD

Voloridge Investment Management Takes Position in DuPont de Nemours

Voloridge Investment Management built a fresh stake in DuPont de Nemours, Inc. (NYSE: DD), buying 1,256,132 shares of the specialty chemicals producer. According to a Form 13F filed with the U.S. Securities and Exchange Commission, the newly established holding carried an estimated value of about $170.4 million at the close of the period.

Position Details and Prior Filing Context

Because this entry represents a fresh buy for the fund, it marks the creation of an entirely new equity holding rather than an adjustment to an existing one. Prior reports from the same reporting season showed mixed sentiment among other major institutional investors regarding the chemical producer. Great Lakes Advisors trimmed its stake by 14%, while Gabelli Funds reduced its holdings by 1.04%. Larger cuts also appeared when Barrow Hanley dropped its position by 61.8%. On the other hand, Canada Life Assurance grew its stake by 19% and Nomura Asset Management expanded its holdings by nearly 59% during a busy stretch of institutional portfolio adjustments.

Stock Price Context and Market Levels

Shares of DuPont de Nemours traded hands around $135.64 on Wednesday. The equity has moved between a 52-week low of $92.49 and a 52-week high of $157.98 over the past year. Financial metrics show the company operating with a forward P/E ratio of 16.3 and a trailing P/E ratio of 55.5, backed by a market valuation near $17.5 billion.

Dividend and Yield Details

Income-focused investors tracking the chemical producer note an annual dividend rate of $2.40 per share. This payout translates to a dividend yield of 1.86% based on current trading levels, alongside a dividend payout ratio of 1.30.

Wall Street Analyst Rating Updates

Analyst firms have continued to update their price targets and outlooks for the stock through the autumn. On October 15, 2026, RBC Capital maintained an outperform rating while moving its price target to $160.00 from $176.00. Earlier in the month on October 13, Barclays initiated coverage with an overweight rating and a $156.00 price target. JP Morgan downgraded the stock to a neutral rating on October 9, 2026, setting a target of $145.00, while Citigroup maintained a buy rating with a $162.00 target on October 7, 2026. UBS kept a buy rating with a $172.00 target on October 5, 2026. Across the broader analyst community, the stock carries a consensus buy recommendation with a mean price target of $170.00 derived from 16 analyst opinions.

Understanding DuPont de Nemours Operations

DuPont de Nemours, Inc. creates technology-based materials and solutions across two core operating divisions: Healthcare & Water Technologies and Diversified Industrials. The firm manufactures specialty components for medical devices, protective garments under the Tyvek brand, and water filtration systems including Amberlite resins and Filmtec reverse osmosis elements. It also supplies construction materials like Styrofoam insulation and Corian solid surfaces, alongside specialized industrial lubricants and adhesives.

What to Watch Next for DuPont

Investors will look ahead to the company's next quarterly earnings report scheduled for November 5, 2026, for updated financial results. Market participants should keep in mind that 13F filings look backward at holdings from the end of the reporting period and do not necessarily reflect current portfolio weightings.